Literature DB >> 26553457

Tenosynovial giant cell tumour (pigmented villonodular synovitis-)-like changes in periprosthetic interface membranes.

Stephan Söder1, Stefan Sesselmann2, Thomas Aigner3, Stephan Oehler4, Abbas Agaimy5.   

Abstract

Tenosynovial giant cell tumour (TSGCT; synonym, pigmented villonodular synovitis (PVNS)) is a rare low-grade mesenchymal neoplasm of either intra-articular or extra-articular origin. The etiopathogenesis of TSGCT is still uncertain, but recent studies showed a translocation involving colony-stimulating factor 1 (CSF-1) gene in a subset of cases. Histological features mimicking TSGCT can sometimes be encountered in periprosthetic interface membranes. To investigate the frequency and morphologic spectrum of this phenomenon, we conducted a systematic analysis of 477 periprosthetic interface membranes and performed immunohistochemical analysis on a subset of lesions compared to genuine TSGCT. In 26 of 477 periprosthetic membrane samples (5 %), at least some TSGCT-like features were found and 18 cases (4 %) strongly resembled it. Wear particles were detected in 100 % of the TSGCT-like lesions but only in 63.3 % of the whole cohort of periprosthetic membranes (p value <0.001). Immunohistochemistry comparing true TSGCT and TSGCT-like membranes showed similar inflammatory infiltrates with slightly elevated CD3+/CD8+ T lymphocytes and a slightly higher proliferation index in TSGCT samples. In conclusion, TSGCT-like changes in periprosthetic membranes likely represent exuberant fibrohistiocytic inflammatory response induced by wear particles and should be distinguished from genuine (neoplastic) TSGCT. Although TSGCT and TSGCT-like periprosthetic membranes represent different entities, their comparable morphology might reflect analogous morphogenesis.

Entities:  

Keywords:  PVNS; PVNS-like; Periprosthetic interface membranes; TSGCT; Tenosynovial giant cell tumour; Wear particles

Mesh:

Substances:

Year:  2015        PMID: 26553457     DOI: 10.1007/s00428-015-1874-9

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  33 in total

1.  Mutant monocyte chemoattractant protein 1 protein attenuates migration of and inflammatory cytokine release by macrophages exposed to orthopedic implant wear particles.

Authors:  Zhenyu Yao; Michael Keeney; Tzu-Hua Lin; Jukka Pajarinen; Katherine Barcay; Heather Waters; Kensuke Egashira; Fan Yang; Stuart Goodman
Journal:  J Biomed Mater Res A       Date:  2013-11-20       Impact factor: 4.396

Review 2.  Revised histopathological consensus classification of joint implant related pathology.

Authors:  V Krenn; L Morawietz; G Perino; H Kienapfel; R Ascherl; G J Hassenpflug; M Thomsen; P Thomas; M Huber; D Kendoff; D Baumhoer; M G Krukemeyer; S Natu; F Boettner; J Zustin; B Kölbel; W Rüther; J P Kretzer; A Tiemann; A Trampuz; L Frommelt; R Tichilow; S Söder; S Müller; J Parvizi; U Illgner; T Gehrke
Journal:  Pathol Res Pract       Date:  2014-10-17       Impact factor: 3.250

3.  Analysis of the distribution and frequency of trisomy 7 in vivo in synovia from patients with osteoarthritis and pigmented villonodular synovitis.

Authors:  A Dahlén; K Broberg; H A Domanski; S Toksvig-Larsen; A Lindstrand; N Mandahl; F Mertens
Journal:  Cancer Genet Cytogenet       Date:  2001-11

4.  Analysis of routine histological evaluation of tissues removed during primary hip and knee arthroplasty.

Authors:  T Lawrence; J T Moskal; D R Diduch
Journal:  J Bone Joint Surg Am       Date:  1999-07       Impact factor: 5.284

5.  Prosthesis-induced synovitis simulating villonodular synovitis.

Authors:  L A Karl; W R Sundstrom
Journal:  Wis Med J       Date:  1991-04

6.  Multinucleated cells in pigmented villonodular synovitis and giant cell tumor of tendon sheath express features of osteoclasts.

Authors:  J M Darling; S R Goldring; Y Harada; M L Handel; J Glowacki; E M Gravallese
Journal:  Am J Pathol       Date:  1997-04       Impact factor: 4.307

Review 7.  Malignant giant cell tumor of synovium (malignant pigmented villonodular synovitis).

Authors:  L J Layfield; A Meloni-Ehrig; K Liu; R Shepard; J M Harrelson
Journal:  Arch Pathol Lab Med       Date:  2000-11       Impact factor: 5.534

8.  Human osteoclast formation and bone resorption by monocytes and synovial macrophages in rheumatoid arthritis.

Authors:  Y Fujikawa; A Sabokbar; S Neale; N A Athanasou
Journal:  Ann Rheum Dis       Date:  1996-11       Impact factor: 19.103

9.  Suppression of wear-particle-induced pro-inflammatory cytokine and chemokine production in macrophages via NF-κB decoy oligodeoxynucleotide: a preliminary report.

Authors:  Tzu-Hua Lin; Zhenyu Yao; Taishi Sato; Michael Keeney; Chenguang Li; Jukka Pajarinen; Fan Yang; Kensuke Egashira; Stuart B Goodman
Journal:  Acta Biomater       Date:  2014-05-09       Impact factor: 8.947

Review 10.  Malignant diffuse-type tenosynovial giant cell tumors: a series of 7 cases comparing with 24 benign lesions with review of the literature.

Authors:  Chien-Feng Li; Jun-Wen Wang; Wen-Wei Huang; Chi-Chen Hou; Shih-Cheng Chou; Hock-Liew Eng; Ching-Nan Lin; Shih-Chen Yu; Hsuan-Ying Huang
Journal:  Am J Surg Pathol       Date:  2008-04       Impact factor: 6.394

View more
  2 in total

Review 1.  [Pigmented villonodular synovitis. A rare differential diagnosis of synovial joint swelling].

Authors:  K A Jendrissek; T Hotfiel; B Swoboda; S Söder; R Janka
Journal:  Z Rheumatol       Date:  2016-03       Impact factor: 1.372

Review 2.  Giant cell tumor of tendon sheath in the wrist that damaged the extensor indicis proprius tendon: a case report and literature review.

Authors:  Qingfang Zhao; Hui Lu
Journal:  BMC Cancer       Date:  2019-11-06       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.